« Previous
Next »
The American Journal of Medicine
Volume 123, Issue 9
, Pages 790-792
, September 2010
Office Management of Peripheral Arterial Disease
References
- ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): Executive Summary. Circulation. 2006;113:1474–1547
- The ankle brachial index is associated with leg function and physical activity: the Walking and Leg Circulation Study. Ann Intern Med. 2002;136:873–883
- Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA. 2001;286:1317–1324
- . Risk factors for peripheral arterial disease in an academic hospital-based geriatrics practice. J Am Geriatr Soc. 2000;48:312–314
- . Prevalence of coexistence of coronary artery disease, peripheral arterial disease, and atherothrombotic brain infarction in men and women ≥62 years of age. Am J Cardiol. 1994;74:64–65
- Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med. 1992;326:381–386
- A propensity-matched study of the association of peripheral arterial disease with cardiovascular outcomes in community-dwelling adults. Am J Cardiol. 2009;103:130–135
- Impact of ramipril in patients with evidence of clinical or subclinical peripheral arterial disease. Eur Heart J. 2004;25:17–24
- . Relation of increased hemoglobin A1c levels to severity of peripheral arterial disease in patients with diabetes mellitus. Am J Cardiol. 2007;99:1468–1469
- . MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet. 2002;360:7–22
- . Effect of simvastatin versus placebo on treadmill exercise time until the onset of intermittent claudication in older patients with peripheral arterial disease at 6 months and at 1 year after treatment. Am J Cardiol. 2003;92:711–712
- . Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ. 2002;324:71–86
- . A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet. 1996;348:1329–1339
- . Beta-adrenergic blocker therapy does not worsen intermittent claudication in subjects with peripheral arterial disease: meta-analysis of randomized controlled trials. Arch Intern Med. 1991;151:1769–1776
- . Effect of beta blockers on incidence of new coronary events in older persons with prior myocardial infarction and symptomatic peripheral arterial disease. Am J Cardiol. 2001;87:1284–1286
- A comparison of cilostazol and pentoxifylline for treating intermittent claudication. Am J Med. 2000;109:523–530
- Diagnosis and treatment of chronic arterial insufficiency of the lower extremities: a critical review. Circulation. 1996;94:3026–3049
Funding: None.
Conflict of Interest: The author states that he has no conflict of interest regarding the content of the article.
Authorship: The author had access to the data and wrote this manuscript.
PII: S0002-9343(10)00386-4
doi: 10.1016/j.amjmed.2010.03.017
© 2010 Elsevier Inc. All rights reserved.
« Previous
Next »
The American Journal of Medicine
Volume 123, Issue 9
, Pages 790-792
, September 2010

